Frontiers in Physiology has officially retracted a research article concerning the molecular mechanisms of diabetic kidney disease. The retraction notice, published on November 5, 2026, targets a study originally released in August 2021. The original paper, authored by Chen Q, Gao C, Wang M, Fei X, and Zhao N, proposed that a specific signaling pathway involving TRIM18 and STAT3 promotes renal epithelial–mesenchymal transition, inflammation, and fibrosis in diabetic kidney disease.
The decision to retract the article was made following an investigation into the figures included in the original research. Concerns were raised regarding the integrity of the images used to support the study’s findings. The authors were given the opportunity to provide an explanation for these discrepancies during the investigative process.
The investigation was conducted in accordance with Frontiers’ policies.
The original article was published in Volume 12 of Frontiers in Physiology in 2021, with the specific article number 709506. It was categorized under the section of Renal Physiology and Pathophysiology. The retraction notice was assigned the DOI 10.3389/fphys.2026.2037793.
The journal thanked the users on PubPeer for bringing the published article to its attention.
The retraction was approved by the Chief Executive Editor of Frontiers. The authors of the original study received formal communication regarding the retraction and were given a chance to respond to the findings of the investigation. This communication has been recorded by the publisher.
The retraction notice was received and accepted on October 22, 2026, before being published on November 5, 2026. It is part of Volume 17 of Frontiers in Physiology for the year 2026. The notice is authored by the Frontiers Editorial Office. The copyright for the retraction notice is held by the Frontiers Editorial Office in 2026, and it is distributed under the Creative Commons Attribution License.
Subject of Research: Retraction of a diabetic kidney disease study due to image integrity concerns
Article Title: Retraction: TRIM18-regulated STAT3 signaling pathway via PTP1B Promotes renal epithelial–mesenchymal transition, inflammation, and fibrosis in diabetic kidney disease
Article References: Frontiers Editorial Office (2026). Retraction: TRIM18-regulated STAT3 signaling pathway via PTP1B Promotes renal epithelial–mesenchymal transition, inflammation, and fibrosis in diabetic kidney disease. Frontiers in Physiology, 17, Article 2037793. https://doi.org/10.3389/fphys.2026.2037793
Image Credits: AI Generated
DOI: 10.3389/fphys.2026.2037793
Keywords: Frontiers in Physiology, Retraction, Diabetic Kidney Disease, Image Integrity, TRIM18, STAT3 Signaling, PTP1B, Epithelial-Mesenchymal Transition, Renal Fibrosis, Research Ethics, PubPeer, Scientific Publishing, Data Integrity, Renal Physiology, Peer Review, Journal Correction, Molecular Pathology, Inflammation, Academic Accountability, Post-Publication Review
News Source: Jerry Hayes. (November 13, 2026). Frontiers Retracts Diabetic Kidney Disease Study Over Image Integrity. Scienmag.



